我们的管线
Our Pipeline

思努赛致力于为神经退行性疾病患者带来First-in-Class及Best-in-Class的诊疗方案。

Candidate Indication Early Discovery Pre-clinical IND Phase I
SST001/FD4
α-Syn PET tracer
与迈克尔·J·福克斯基金会(MJFF)建立合作
PD, MSA, DLB
IIT completed
SST002
PET tracer
Undisclosed
SSA001
Novel Biomarker
Undisclosed
SSA002
Novel Biomarker
Undisclosed
Candidate
SST001/FD4
α-Syn PET tracer
与迈克尔·J·福克斯基金会(MJFF)建立合作
IndicationPD, MSA, DLB
Early Discovery Pre-clinical IND Phase I
IIT completed
Candidate
SST002
PET tracer
IndicationUndisclosed
Early Discovery Pre-clinical IND Phase I
Candidate
SSA001
Novel Biomarker
IndicationUndisclosed
Early Discovery Pre-clinical IND Phase I
Candidate
SSA002
Novel Biomarker
IndicationUndisclosed
Early Discovery Pre-clinical IND Phase I